Metoprolol Succinate
Product Images NDC 53002-2612

7 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 53002-2612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

1 (Image 2)

1 (Image 2)
Chemical structure diagram of metoprolol succinate, showing the molecular arrangement of atoms and bonds typical for this active ingredient.*
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
The packaging label shows metoprolol succinate extended-release tablets. It is a white rectangular box with blue and green accents displaying the proprietary name metoprolol succinate. The label includes strength information, quantity, and the manufacturer RPK Pharmaceuticals, Inc. The box layout is typical for prescription medication packaging.*
FDA Label Image

2 (Image 5)

2 (Image 5)
Chemical structure of metoprolol succinate showing two metoprolol moieties and one succinate moiety. The diagram includes hydroxyl, ether, and amine functional groups and the succinate dicarboxylic acid portion.*
FDA Label Image

1 (Image 6)

1 (Image 6)
A forest plot presenting results for subgroups in the MERIT-HF study. It compares the relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality hospitalization for heart failure, each as time to first event. Subgroups include geographic location, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate. The plot contrasts metoprolol succinate extended-release versus placebo.*
FDA Label Image

Label Image (Lbl530022612)

Label Image (Lbl530022612)
The image shows a medication label for Metoprolol Succinate 50 mg extended-release tablets. It includes directions to take one tablet daily with a meal or as directed. The label indicates a quantity of 100 tablets and includes barcode details. The labeler is RPK Pharmaceuticals, Inc. Several sections also provide placeholders for clinic name, patient information, prescribing provider, and billing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.